Media Coverage
Aug 21, 2024
InnovationRx: COVID May Be Causing Mental Illness—And Rewiring Our Brains
See More
Aug 21, 2024
InnovationRx: COVID May Be Causing Mental Illness—And Rewiring Our Brains
See More
Media Coverage
Aug 21, 2024
PreciseDx Secures $20.7 Million Series B to Advance AI-Powered Cancer Risk Assessments
See More
Aug 21, 2024
PreciseDx Secures $20.7 Million Series B to Advance AI-Powered Cancer Risk Assessments
See More
Media Coverage
Aug 21, 2024
PreciseDx Secures $20.7 Million Series B
See More
Aug 21, 2024
PreciseDx Secures $20.7 Million Series B
See More
Media Coverage
Aug 21, 2024
PreciseDx Raises $20.7M in Series B Funding
See More
Aug 21, 2024
PreciseDx Raises $20.7M in Series B Funding
See More
Media Coverage
Aug 21, 2024
PreciseDx Raises $20.7M in Series B Round
See More
Aug 21, 2024
PreciseDx Raises $20.7M in Series B Round
See More
Media Coverage
Aug 21, 2024
PreciseDx picks up $20.7M to advance AI-based breast cancer risk assessment
See More
Aug 21, 2024
PreciseDx picks up $20.7M to advance AI-based breast cancer risk assessment
See More
Media Coverage
Aug 2, 2024
As AI-Based Diagnostics Proliferate, Stakeholders Strive for Regulation Without Stifling Innovation
See More
Aug 2, 2024
As AI-Based Diagnostics Proliferate, Stakeholders Strive for Regulation Without Stifling Innovation
See More
Media Coverage
Jul 31, 2024
News We’re Watching: FDA Warning Letters; First Hysterectomy With MIRA Robot; DOJ Finalizes Rule On Accessibility; And More
See More
Jul 31, 2024
News We’re Watching: FDA Warning Letters; First Hysterectomy With MIRA Robot; DOJ Finalizes Rule On Accessibility; And More
See More
Jul 23, 2024
PreciseDx Announces Publication of Its Cost Impact Study, Payer Impact of PreciseBreast™(PDxBr) to Identify Breast Cancer Recurrence, in the Journal Of Medical Economics
See More
Jul 23, 2024
PreciseDx Announces Publication of Its Cost Impact Study, Payer Impact of PreciseBreast™(PDxBr) to Identify Breast Cancer Recurrence, in the Journal Of Medical Economics
See More
Publications
Jul 9, 2024
U.S. Payer Budget Impact of Using an AI-Augmented Cancer Risk Discrimination Digital Histopathology Platform to Identify High-Risk of Recurrence in Women with Early-Stage Invasive Breast Cancer
See More
Jul 9, 2024
U.S. Payer Budget Impact of Using an AI-Augmented Cancer Risk Discrimination Digital Histopathology Platform to Identify High-Risk of Recurrence in Women with Early-Stage Invasive Breast Cancer
See More
No results.
Contact us today to learn more about PreciseBreast.
